FDA Approves IV Opioid Olinvyk for Short-term Use
The Food and Drug Administration (FDA) approved the opioid Olinvyk, also known as oliceridine, for managing moderate to severe pain on adults. The intravenous (IV) opioid analgesic is an excellent short-term alternative in acute or inadequate pain treatments. Olinvyk is a full opioid agonist indicated for short-term IV use in controlled clinical settings and hospitals…
